Mounting evidence supported that mutations in SLC25A20 are closely associated with carnitine-acylcarnitine-translocase deficiency, resulting in a variety of metabolic diseases, which further implies its critical physiological functions (Chinen et al., 2020; Vatanavicharn et al., 2015). Here, SLC25A20 is linked to metabolic disease.